Smart for Life Announces FY 2021 Financial Results
Company Achieves 360% Increase in Revenue in 2021 through Implementation of Successful Acquisition Strategy Completed Three Material Acquisitions in Last...
Company Achieves 360% Increase in Revenue in 2021 through Implementation of Successful Acquisition Strategy Completed Three Material Acquisitions in Last...
Highlights Include $7,266,146 Increase in Shareholder EquityROSEVILLE, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- InnerScope Hearing Technologies Inc. (OTC: INND)...
LAWRENCEVILLE, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation...
SAN FRANCISCO, April 01, 2022 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for the...
Announcement marks first clinical trial in humans of Ocugen’s modifier gene therapy platformMALVERN, Pa., April 01, 2022 (GLOBE NEWSWIRE) --...
ROSELAND, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery...
The Company also announces completion of enrollment in 12-week, Phase 1b trial of pemvidutide in subjects with non-alcoholic fatty liver...
RAMSEY, N.J. and BOCA RATON, Fla., April 01, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the...
Experimental trial research presented at the American College of Cardiology’s 71st Annual Scientific Session showed that the combinations of EPA/atorvastatin...
HOUSTON, April 01, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to...
NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider...
Philogen Reports Full Year 2021 Results and Provides Corporate Update Patient enrolment in Nidlegy™’s European Phase III trial for the...
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinformatics to advance...
Company announcement no. 4 - 221 April 2022 Reporting of transactions made by persons discharging managerial responsibilities and persons closely...
COPENHAGEN, Denmark, April 1, 2022 – In accordance with the Company’s remuneration policy, the Board of Directors of Bavarian...
KODEX-EPD cardiac imaging and mapping system from Philips Philips KODEX-EPD cryoballoon procedure Philips GlideLight Laser Sheath for lead management Philips...
Press release (MAR)Malmö, Sweden, April 1, 2022 FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis The Food and...
April 1, 2022Announcement no. 6 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in...
EUROAPI listing on Euronext Paris expected on May 6, 2022 French AMF approved EUROAPI’s listing prospectus EUROAPI first day of...
TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven...